Ares Management

ARESNYSEUSD

THESIS ALERT

Email me when the ARES thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$137.89
−$1.52 (−1.09%)Today 1M +18.93%
After hours$138.00+0.08%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$139.41
Prior regular-session close from the quote source.
$137.66–$141.91
Regular-session low and high so far today.
1.4M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$95.80–$181.19
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own ARES if it keeps fundraising, preserves performance, and manages corporate liquidity, the business compunds predictable cash and fee growth.

ARES price history

Latest price$137.89Today−$1.52 (-1.09%)
ARES +17.66%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Ares' revenue growth will continue to be driven primarily by AUM-driven management fees plus periodic performance/realization gains; as long as fundraising and investment realizations continue, revenue will remain resilient.StrengtheningMateriality: High

    Revenue increased year-over-year: $3,236,285,000 (2023) -> $3,690,668,000 (2024) -> $4,755,618,000 (2025). If true, owners get predictable fee growth plus occasional earnings uplifts from realizations; if false, revenue could fall or become more volatile, compressing valuation.

    Watch: Large institutional clients reduce target allocations to alternatives or move mandates to competitors (Blackstone/KKR/others) lowering AUM and fee pools.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

  • Ares' operating cash flow will remain strongly positive because its business converts recurring fees and realized investment proceeds into corporate cash when fundraising and realizations are healthy.StrengtheningMateriality: High

    Operating cash flow swung from negative in prior years to positive: -$233,261,000 (2023) -> $2,791,154,000 (2024) -> $3,266,959,000 (2025). Sustained positive operating cash flow funds GP investments, distributions and buybacks — critical to shareholder returns and the ability to pursue opportunistic deals.

    Watch: If fundraising stalls or realizations dry up, fee cash receipts and realized proceeds could drop and push operating cash flow down.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow swung from negative in prior years to positive: -$233,261,000 (2023) -> $2,791,154,000 (2024) -> $3,266,959,000 (2025).

    Open source ↗
  • Ares' distribution and investment-scale (headcount and platform breadth) provide a durable advantage in fundraising and deal access that preserves pricing/premium for funds and supports fee retention.StrengtheningMateriality: Medium

    Profile reports over 4,250 employees including 1,650+ professionals and global footprint (55 offices, 25+ countries). If scale keeps winning mandates, management fees and carry remain available; if scale fails to translate into competitive fundraising, the company's core fee base erodes.

    Watch: Competitors with larger or more specialized distribution raise faster or win mandates (e.g., larger private markets platforms capturing institutional flows).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Profile reports over 4,250 employees including 1,650+ professionals and global footprint (55 offices, 25+ countries).

    Open source ↗
  • Corporate liquidity is a gating factor: the drop in Ares' reported cash suggests management uses corporate cash for GP commitments, investments or returns — if corporate cash remains low relative to commitments, future opportunistic investments and distributions will be constrained.HoldingMateriality: Medium

    Cash declined materially year-over-year: $1,507,976,000 (2024) -> $488,896,000 (2025), implying significant corporate deployment or different cash timing. Low corporate cash increases dependence on external financing for GP investments and buybacks, raising risk in stressed markets; ample liquidity enables opportunistic deployments and supports performance fees.

    Watch: Management could offset low cash through increased corporate borrowings or committed credit facilities.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Cash declined materially year-over-year: $1,507,976,000 (2024) -> $488,896,000 (2025), implying significant corporate deployment or different cash timing.

    Open source ↗
  • For shareholders, sustaining and growing net income through higher recurring fees and realized gains is necessary to justify premium expectations embedded in the share price; if net income growth falters, multiple compression is likely.HoldingMateriality: Medium

    Reported net income: $474,326,000 (2023) -> $463,742,000 (2024) -> $527,362,000 (2025), showing recovery and improvement in 2025. Net income tracks earnings power and distributable capacity; failing to grow earnings when priced for growth causes share-price downside.

    Watch: If performance fee realizations are volatile or decline, net income will be lumpy and could miss investor expectations.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Reported net income: $474,326,000 (2023) -> $463,742,000 (2024) -> $527,362,000 (2025), showing recovery and improvement in 2025.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Ares' revenue growth will continue to be driven primarily by AUM-driven management fees plus periodic performance/realization gains; as long as fundraising and investment realizations continue, revenue will remain resilient. If true, owners get predictable fee growth plus occasional earnings uplifts from realizations; if false, revenue could fall or become more volatile, compressing valuation.

Ares' operating cash flow will remain strongly positive because its business converts recurring fees and realized investment proceeds into corporate cash when fundraising and realizations are healthy. Sustained positive operating cash flow funds GP investments, distributions and buybacks — critical to shareholder returns and the ability to pursue opportunistic deals.

Ares' distribution and investment-scale (headcount and platform breadth) provide a durable advantage in fundraising and deal access that preserves pricing/premium for funds and supports fee retention. If scale keeps winning mandates, management fees and carry remain available; if scale fails to translate into competitive fundraising, the company's core fee base erodes.

Corporate liquidity is a gating factor: the drop in Ares' reported cash suggests management uses corporate cash for GP commitments, investments or returns — if corporate cash remains low relative to commitments, future opportunistic investments and distributions will be constrained. Low corporate cash increases dependence on external financing for GP investments and buybacks, raising risk in stressed markets; ample liquidity enables opportunistic deployments and supports performance fees.

For shareholders, sustaining and growing net income through higher recurring fees and realized gains is necessary to justify premium expectations embedded in the share price; if net income growth falters, multiple compression is likely. Net income tracks earnings power and distributable capacity; failing to grow earnings when priced for growth causes share-price downside.

All standing thesis claims
Original report summary

it keeps fundraising, preserves performance, and manages corporate liquidity, the business compunds predictable cash and fee growth.

Evidence assessed Oct 19, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for ARES Management

Where the evidence on ARES Management stands: Holding on the latest evidence (Oct 19, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Ares' revenue growth will continue to be driven primarily by AUM-driven management fees plus periodic performance/realization gains; as long as fundraising and investment realizations continue, revenue will remain resilient.

  • Ares' operating cash flow will remain strongly positive because its business converts recurring fees and realized investment proceeds into corporate cash when fundraising and realizations are healthy.

    sec.gov ↗

  • Ares' distribution and investment-scale (headcount and platform breadth) provide a durable advantage in fundraising and deal access that preserves pricing/premium for funds and supports fee retention.

    sec.gov ↗

  • Corporate liquidity is a gating factor: the drop in Ares' reported cash suggests management uses corporate cash for GP commitments, investments or returns — if corporate cash remains low relative to commitments, future opportunistic investments and distributions will be constrained.

    sec.gov ↗

  • For shareholders, sustaining and growing net income through higher recurring fees and realized gains is necessary to justify premium expectations embedded in the share price; if net income growth falters, multiple compression is likely.

    sec.gov ↗

Bear case: what would count against it

  • Large institutional clients reduce target allocations to alternatives or move mandates to competitors (Blackstone/KKR/others) lowering AUM and fee pools.

  • If fundraising stalls or realizations dry up, fee cash receipts and realized proceeds could drop and push operating cash flow down.

    sec.gov ↗

  • Competitors with larger or more specialized distribution raise faster or win mandates (e.g., larger private markets platforms capturing institutional flows).

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · ARES Management

Loading the break-condition record for ARES Management.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Regulation FD disclosure.

    ARES Management filed an SEC 8-K on 2026-09-30: Regulation FD disclosure. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    ARES Management filed an SEC 8-K on 2026-07-31: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    ARES Management filed an SEC 8-K on 2026-07-10: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large institutional clients reduce target allocations to alternatives or move mandates to competitors (Blackstone/KKR/others) lowering AUM and fee pools.
  • If fundraising stalls or realizations dry up, fee cash receipts and realized proceeds could drop and push operating cash flow down.
  • Competitors with larger or more specialized distribution raise faster or win mandates (e.g., larger private markets platforms capturing institutional flows).
  • Management could offset low cash through increased corporate borrowings or committed credit facilities.
  • If performance fee realizations are volatile or decline, net income will be lumpy and could miss investor expectations.

ARES news

Loading headlines…

Financial statements

ARES income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

ARES: quick answers

What is ARES's short interest?
As of October 30, 2026, 15.2M ARES shares were sold short, 6.77% of its shares outstanding, down 3.0% from the count before. At the stock's average daily volume that is 6.7 days to cover. FINRA publishes the count twice a month. ARES short interest history
Have members of Congress traded ARES?
Reports made public in the last 90 days disclose 2 trades in ARES by 1 filer: 1 purchase and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed ARES trade
Which well-known investors own ARES?
2 of the 37 well-known funds tracked here reported ARES shares in their latest 13F filings. By share of the fund's portfolio: Third Point (Dan Loeb), 0.9%; Soros Fund Management (George Soros), 0.1%. Fund portfolios

ARES in well-known investors’ portfolios

2 of 37 funds reported ARES shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Dan LoebThird Point0.89%$41.7MNewQ2 2026
George SorosSoros Fund Management0.07%$6.0M−72.4%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.